JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1998; 31:241-251
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Califf, R.
Right arrow Articles by Ohman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Califf, R.
Right arrow Articles by Ohman, E.

Myonecrosis after revascularization procedures

RM Califf, AE Abdelmeguid, RE Kuntz, JJ Popma, CJ Davidson, EA Cohen, NS Kleiman, KW Mahaffey, EJ Topol, CJ Pepine, RJ Lipicky, CB Granger, RA Harrington, BE Tardiff, BS Crenshaw, RP Bauman, BD Zuckerman, BR Chaitman, JA Bittl, and EM Ohman

Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA. calif001@mc.duke.edu

The detection of elevated cardiac enzyme levels and the occurrence of electrocardiographic (ECG) abnormalities after revascularization procedures have been the subject of recent controversy. This report represents an effort to achieve a consensus among a group of researchers with data on this subject. Creatine kinase (CK) or CK-MB isoenzyme (CK-MB) elevations occur in 5% to 30% of patients after a percutaneous intervention and commonly during coronary artery bypass graft surgery (CABG). Although Q wave formation is rare, other ECG changes are common. The rate of detection is highly dependent on the intensity of enzyme and ECG measurement. Because most events occur without the development of a Q wave, the ECG will not definitively diagnose them; even the ECG criteria for Q wave formation signifying an important clinical event have been variable. At least 10 studies evaluating > 10,000 patients undergoing percutaneous intervention have demonstrated that elevation of CK or CK-MB is associated not only with a higher mortality, but also with a higher risk of subsequent cardiac events and higher cost. Efforts to identify a specific cutoff value below which the prognosis is not impaired have not been successful. Rather, the risk of adverse outcomes increases with any elevation of CK or CK-MB and increases further in proportion to the level of intervention. This information complements similar previous data on CABG. Obtaining preprocedural and postprocedural ECGs and measurement of serial cardiac enzymes after revascularization are recommended. Patients with enzyme levels elevated more than threefold above the upper limit of normal or with ECG changes diagnostic for Q wave myocardial infarction (MI) should be treated as patients with an MI. Patients with more modest elevations should be observed carefully. Clinical trials should ensure systematic evaluation for myocardial necrosis, with attention paid to multivariable analysis of risk factors for poor long-term outcome, to determine the extent to which enzyme elevation is an independent risk factor after considering clinical history, coronary anatomy, left ventricular function and clinical evidence of ischemia. In addition, tracking of enzyme levels in clinical trials is needed to determine whether interventions that reduce periprocedural enzyme elevation also improve mortality.


This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
Y. J. Hong, M. H. Jeong, Y. Ahn, D. S. Sim, J. W. Chung, J. S. Cho, N. S. Yoon, H. J. Yoon, J. Y. Moon, K. H. Kim, et al.
Plaque Prolapse After Stent Implantation in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Analysis
J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 489 - 497.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Y. Wang, E. D. Peterson, D. Dai, H. V. Anderson, S. V. Rao, R. G. Brindis, M. T. Roe, and on behalf of the National Cardiovascular Data Regi
Patterns of Cardiac Marker Surveillance After Elective Percutaneous Coronary Intervention and Implications for the Use of Periprocedural Myocardial Infarction as a Quality Metric: A Report From the National Cardiovascular Data Registry (NCDR)
J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2068 - 2074.
[Full Text] [PDF]


Home page
Card Surg AdultHome page
J. M. Wilson and J. T. Willerson
Myocardial Revascularization with Percutaneous Devices
Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598.
[Full Text]


Home page
Clin. Chem.Home page
NACB WRITING GROUP MEMBERS, A. H.B. Wu, A. S. Jaffe, F. S. Apple, R. L. Jesse, G. L. Francis, D. A. Morrow, L. K. Newby, J. Ravkilde, W.H. W. Tang, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure
Clin. Chem., December 1, 2007; 53(12): 2086 - 2096.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
W. D Cahoon Jr and M. A Crouch
Preprocedural Statin Therapy in Percutaneous Coronary Intervention
Ann. Pharmacother., October 1, 2007; 41(10): 1687 - 1693.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. B. King III, T. Aversano, W. L. Ballard, R. H. Beekman III, M. J. Cowley, S. G. Ellis, D. P. Faxon, E. L. Hannan, J. W. Hirshfeld Jr, A. K. Jacobs, et al.
ACCF/AHA/SCAI 2007 Update of the Clinical Competence Statement on Cardiac Interventional Procedures: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures)
J. Am. Coll. Cardiol., July 3, 2007; 50(1): 82 - 108.
[Full Text] [PDF]


Home page
CirculationHome page
D. E. Cutlip, S. Windecker, R. Mehran, A. Boam, D. J. Cohen, G.-A. van Es, P. Gabriel Steg, M.-a. Morel, L. Mauri, P. Vranckx, et al.
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Circulation, May 1, 2007; 115(17): 2344 - 2351.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.-H. Lee, A. Low, B.-C. Tai, M. Co, M. Y. Chan, J. Lim, Y.-T. Lim, and H.-C. Tan
Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study
Eur. Heart J., January 1, 2007; 28(1): 19 - 25.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
B. B. Carmichael, R. M. Setser, A. E. Stillman, M. L. Lieber, N. G. Smedira, P. M. McCarthy, R. C. Starling, J. B. Young, J. A. Weaver, A. G. Lawrence, et al.
Effects of Surgical Ventricular Restoration on Left Ventricular Function: Dynamic MR Imaging
Radiology, December 1, 2006; 241(3): 710 - 717.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Prasad, M. Singh, A. Lerman, R. J. Lennon, D. R. Holmes Jr, and C. S. Rihal
Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term Mortality
J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1765 - 1770.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Larose
Below Radar: Contributions of Cardiac Magnetic Resonance to the Understanding of Myonecrosis After Percutaneous Coronary Intervention
Circulation, August 15, 2006; 114(7): 620 - 622.
[Full Text] [PDF]


Home page
Eur Heart JHome page
W. L. Miller, K. N. Garratt, M. F. Burritt, R. J. Lennon, G. S. Reeder, and A. S. Jaffe
Baseline troponin level: key to understanding the importance of post-PCI troponin elevations
Eur. Heart J., May 1, 2006; 27(9): 1061 - 1069.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. I. Lev, R. T. Patel, K. J. Maresh, S. Guthikonda, J. Granada, T. DeLao, P. F. Bray, and N. S. Kleiman
Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention: The Role of Dual Drug Resistance
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 27 - 33.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. A. Pascual, J. M. Arribas, P. L. Tornel, F. Marin, C. Oliver, M. Ahumada, J. Gomez-Plana, P. Martinez, R. Arcas, and M. Valdes
Preoperative Statin Therapy and Troponin T Predict Early Complications of Coronary Artery Surgery
Ann. Thorac. Surg., January 1, 2006; 81(1): 78 - 83.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. I. Lev, R. T. Patel, K. J. Maresh, S. Guthikonda, J. Granada, T. DeLao, P. F. Bray, and N. S. Kleiman
Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention: The Role of Dual Drug Resistance
J. Am. Coll. Cardiol., December 13, 2005; (2005) j.jacc.2005.08.058v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Herrmann
Peri-procedural myocardial injury: 2005 update
Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Thielmann, P. Massoudy, A. Schmermund, M. Neuhauser, G. Marggraf, M. Kamler, U. Herold, I. Aleksic, K. Mann, M. Haude, et al.
Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery
Eur. Heart J., November 2, 2005; 26(22): 2440 - 2447.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Liistro, P Angioli, G Falsini, K Ducci, S Baldassarre, A Burali, and L Bolognese
Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome: comparison with younger patients regarding 30 day and long term outcome
Heart, October 1, 2005; 91(10): 1284 - 1288.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Bahrmann, H R Figulla, M Wagner, M Ferrari, A Voss, and G S Werner
Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions
Heart, September 1, 2005; 91(9): 1186 - 1192.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. L. Bhatt and E. J. Topol
Periprocedural Cardiac Enzyme Elevation Predicts Adverse Outcomes
Circulation, August 9, 2005; 112(6): 906 - 922.
[Full Text] [PDF]


Home page
CirculationHome page
D. E. Cutlip and R. E. Kuntz
Cardiac Enzyme Elevation After Successful Percutaneous Coronary Intervention Is Not an Independent Predictor of Adverse Outcomes
Circulation, August 9, 2005; 112(6): 916 - 923.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C. Cavallini, S. Savonitto, R. Violini, G. Arraiz, M. Plebani, Z. Olivari, P. Rubartelli, S. Battaglia, L. Niccoli, G. Steffenino, et al.
Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study
Eur. Heart J., August 1, 2005; 26(15): 1494 - 1498.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J Steuer, F Granath, U de Faire, A Ekbom, and E Stahle
Increased risk of heart failure as a consequence of perioperative myocardial injury after coronary artery bypass grafting
Heart, June 1, 2005; 91(6): 754 - 758.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. B. Selvanayagam, I. Porto, K. Channon, S. E. Petersen, J. M. Francis, S. Neubauer, and A. P. Banning
Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury: Insights From Cardiovascular Magnetic Resonance Imaging
Circulation, March 1, 2005; 111(8): 1027 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Ramsay, S. Shernan, J. Fitch, P. Finnegan, T. Todaro, T. Filloon, and N. A. Nussmeier
Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves
J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 300 - 306.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. J. Cohen, S. A. Murphy, D. S. Baim, T. A. Lavelle, R. H. Berezin, D. E. Cutlip, K. K.L. Ho, R. E. Kuntz, and the SAFER Trial Investigators
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: Results from the SAFER trial
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1801 - 1808.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Briguori, A. Colombo, F. Airoldi, A. Violante, A. Focaccio, P. Balestrieri, P. Paolo Elia, B. Golia, S. Lepore, G. Riviezzo, et al.
Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction
Eur. Heart J., October 2, 2004; 25(20): 1822 - 1828.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Cutlip, A. G. Chhabra, D. S. Baim, M. S. Chauhan, S. Marulkar, J. Massaro, A. Bakhai, D. J. Cohen, R. E. Kuntz, and K. K.L. Ho
Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials
Circulation, September 7, 2004; 110(10): 1226 - 1230.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Steuer, T. Bjerner, O. Duvernoy, L. Jideus, L. Johansson, H. Ahlstrom, E. Stahle, and B. Lindahl
Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging
Eur. Heart J., August 1, 2004; 25(15): 1293 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Thielmann, P. Massoudy, G. Marggraf, S. Knipp, A. Schmermund, J. Piotrowski, R. Erbel, and H. Jakob
Role of troponin I, myoglobin, and creatine kinase for the detection of early graft failure following coronary artery bypass grafting
Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 102 - 109.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. D. Verrier, S. K. Shernan, K. M. Taylor, F. Van de Werf, M. F. Newman, J. C. Chen, M. Carrier, A. Haverich, K. J. Malloy, P. X. Adams, et al.
Terminal Complement Blockade With Pexelizumab During Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass: A Randomized Trial
JAMA, May 19, 2004; 291(19): 2319 - 2327.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W.-H. Chen, P.-Y. Lee, W. Ng, H.-F. Tse, and C.-P. Lau
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1122 - 1126.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M.T. Roe, K.W. Mahaffey, R. Kilaru, J.H. Alexander, K.M. Akkerhuis, M.L. Simoons, R.A. Harrington, B.E. Tardiff, C.B. Granger, E.M. Ohman, et al.
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes
Eur. Heart J., February 2, 2004; 25(4): 313 - 321.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. L. Miller, K. N. Garratt, M. F. Burritt, G. S. Reeder, and A. S. Jaffe
Timing of Peak Troponin T and Creatine Kinase-MB Elevations After Percutaneous Coronary Intervention
Chest, January 1, 2004; 125(1): 275 - 280.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Eefting, H. Nathoe, D. van Dijk, E. Jansen, J. Lahpor, P. Stella, W. Suyker, J. Diephuis, H. Suryapranata, S. Ernst, et al.
Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty
Circulation, December 9, 2003; 108(23): 2870 - 2876.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Iakovou, G. S. Mintz, G. Dangas, A. Abizaid, R. Mehran, Y. Kobayashi, A. J. Lansky, E. D. Aymong, E. Nikolsky, G. W. Stone, et al.
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study
J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1900 - 1905.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. O. Williams
A twist in our understanding of enzyme elevation after coronary intervention
J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1906 - 1908.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. P. A. Ioannidis, E. Karvouni, and D. G. Katritsis
Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention
J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1406 - 1411.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. K. Nallamothu and E. R. Bates
Periprocedural myocardial infarction and mortality: Causality versus association
J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1412 - 1414.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. A. Henderson, S. J. Pocock, T. C. Clayton, R. Knight, K. A. A. Fox, D. G. Julian, D. A. Chamberlain, and Second Randomized Intervention Treatment of Angina
Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy
J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1161 - 1170.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. Gavard, B. R. Chaitman, S. Sakai, K. Stocke, N. Danchin, L. Erhardt, R. Gallo, E. Chi, A. Jessel, and P. Theroux
Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial
J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 807 - 813.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G Sangiorgi and A Colombo
Embolic protection devices
Heart, September 1, 2003; 89(9): 990 - 992.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. N. Levine, M. J. Kern, P. B. Berger, D. L. Brown, L. W. Klein, D. J. Kereiakes, T. A. Sanborn, A. K. Jacobs, and for the American Heart Association Diagnostic and
Management of Patients Undergoing Percutaneous Coronary Revascularization
Ann Intern Med, July 15, 2003; 139(2): 123 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Puskas, W. H. Williams, P. G. Duke, J. R. Staples, K. E. Glas, J. J. Marshall, M. Leimbach, P. Huber, S. Garas, B. H. Sammons, et al.
Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: A prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 797 - 808.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Holmvang, P. Clemmensen, B. Lindahl, B. Lagerqvist, P. Venge, G. Wagner, L. Wallentin, and P. Grande
Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment
J. Am. Coll. Cardiol., March 19, 2003; 41(6): 905 - 915.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Chen-Scarabelli and T. Scarabelli
Comparison of troponin T and creatine Kinase-MB fraction in evaluating cardiac patients postoperatively
J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1065 - 1065.
[Full Text] [PDF]


Home page
HeartHome page
G Ando', A Gaspardone, and I Proietti
Acute thrombosis of the sinus node artery: arrhythmological implications
Heart, February 1, 2003; 89(2): e5 - 5.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. M. Nathoe, D. van Dijk, E. W.L. Jansen, W. J.L. Suyker, J. C. Diephuis, W.-J. van Boven, A. B. de la Riviere, C. Borst, C. J. Kalkman, D. E. Grobbee, et al.
A Comparison of On-Pump and Off-Pump Coronary Bypass Surgery in Low-Risk Patients
N. Engl. J. Med., January 30, 2003; 348(5): 394 - 402.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Haase, A. Sharma, A. Fielitz, S. Uchino, J. Rocktaeschel, R. Bellomo, L. Doolan, G. Matalanis, A. Rosalion, B. F. Buxton, et al.
On-pump coronary artery surgery versus off-pump exclusive arterial coronary grafting: a matched cohort comparison
Ann. Thorac. Surg., January 1, 2003; 75(1): 62 - 67.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. J. Brener, B. W. Lytle, J. P. Schneider, S. G. Ellis, and E. J. Topol
Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality
J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1961 - 1967.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Yamamoto, H. Ito, K. Iwakura, S. Kawano, M. Ikushima, T. Masuyama, T. Ogihara, and K. Fujii
Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: Insight into mechanisms of microvascular dysfunction
J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1755 - 1760.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Herrmann, A. Lerman, D. Baumgart, L. Volbracht, R. Schulz, C. von Birgelen, M. Haude, G. Heusch, and R. Erbel
Preprocedural Statin Medication Reduces the Extent of Periprocedural Non-Q-Wave Myocardial Infarction
Circulation, October 22, 2002; 106(17): 2180 - 2183.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. P. Taggart, S. Neubauer, M. A. Costa, D. P. Foley, P. W. Serruys, R. G. Carere, S. V. Lichtenstein, V. de Valk, W. Lindenboom, P. C.H. Roose, et al.
Incidence, Predictors, and Significance of Abnormal Cardiac Enzyme Rise in Patients Treated With Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS) * Response
Circulation, September 24, 2002; 106 (13): e55 - e56.
[Full Text] [PDF]


Home page
CirculationHome page
S. G. Ellis, D. Chew, A. Chan, P. L. Whitlow, J. P. Schneider, and E. J. Topol
Death Following Creatine Kinase-MB Elevation After Coronary Intervention: Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy
Circulation, September 3, 2002; 106(10): 1205 - 1210.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
C. Nass and L. A. Fleisher
Diagnosing Perioperative Myocardial Infarction in Cardioth oracic and Vascular Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2002; 6(3): 219 - 227.
[Abstract] [PDF]


Home page
Eur Heart JHome page
J. Steuer, L.-G. Horte, B. Lindahl, and E. Stahle
Impact of perioperative myocardial injury on early and long-term outcome after coronary artery bypass grafting
Eur. Heart J., August 1, 2002; 23(15): 1219 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. J. Cantor, L. K. Newby, R. H. Christenson, R. H. Tuttle, V. Hasselblad, P. W. Armstrong, D. J. Moliterno, R. M. Califf, E. J. Topol, E. M. Ohman, et al.
Prognostic significance of elevated troponin i after percutaneous coronary intervention
J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1738 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Colombo and G. Stankovic
Nothing is lower than 0, and 3 is closer to 0 than to 5--medicine is not arithmetic
Eur. Heart J., June 1, 2002; 23(11): 840 - 842.
[Full Text]